当前位置：首页 > 文献互助 > 互助详情

FB-7011: A Novel, Long-Duration siRNA Dual-Targeting Both Complement Factor B (CFB) and Mannan-Binding Lectin Serine Protease 2 (MASP2) Exhibits Therapeutic Potential for Treatment of IgAN复制

用户jFEnCL9cudRQ 2小时前 26 10 求助中 帖子自动结束时间: 2026-03-05 09:00:02

1. 文件大小不能超过300M, 允许上传文档或压缩包等

2. 请确保上传文献的真实性、完整性，不得对原文做任何修改

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1681/asn.2025hjw1w0x0复制

文献链接: https://journals.lww.com/10.1681/ASN.2025hjw1w0x0复制

其他信息:

出版社: Ovid Technologies (Wolters Kluwer Health)
作者: Michael Zhiyan Wang

上一篇：Dyslipidemia in Diabetes: Navigating a Complex Landscape for Improved Cardiovascular Outcomes

下一篇：Oxides and Carbonates Accelerate Copper Instability in CO2 Electroreduction

互助时间线

2026-02-28 09:00:02 [发起求助]

最新发布的求助

Flash floods: why are more of them devastating the world’s driest regions? 3分钟前
Developing a machine learning model for detecting depression, anxiety, and apathy in older adults with mild cognitive impairment using speech and facial expressions: A cross-sectional observational study 6分钟前
Validation of 18F-fluoro-4-thia-palmitate as a PET probe for myocardial fatty acid oxidation: effects of hypoxia and composition of exogenous fatty acids 21分钟前
Comparison of uptake of CardioPET, a potential PET tracer for myocardial fatty acid utilization and BFPET, a possible PET blood flow marker in fed vs fasted mice 25分钟前
Using circular dichroism spectra to estimate protein secondary structure 38分钟前
A Series of Novel, Highly Potent, and Orally Bioavailable Next-Generation Tricyclic Peptide PCSK9 Inhibitors 1小时前
Discovery of novel and potent 2-aminopyrazine-based HPK1 inhibitors enhancing T-cell immunity against cancer 1小时前
高级别脑膜瘤新药临床开发的中国专家共识 1小时前
New Oral PCSK9 Inhibitor: “MK-0616” 1小时前
MK-0616: an oral PCSK9 inhibitor for hypercholesterolemia treatment 1小时前
CD44 is associated with papillary thyroid carcinoma metastasis via potential modulation of the immunosuppressive tumor microenvironment 2小时前
FB-7013: A Novel, Long-Duration siRNA Targeting Mannan-Binding Lectin Serine Protease 2 (MASP2) Exhibits Therapeutic Potential for Treatment of IgAN 2小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com